← Open Payments lookup

RUPINDER GREWAL: Open Payments

NPI 1689136392 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,420 in 69 payments from 17 companies in 2025. Trend: 2023 $217 · 2024 $1,621 · 2025 $1,420

Food & beverage: $1,420
CompanyPaymentsAmount
ABBVIE INC.18$364
Takeda Pharmaceuticals U.S.A., Inc.8$149
Lundbeck LLC6$117
Noven Therapeutics, LLC5$97
Axsome Therapeutics, Inc.4$91
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$89
Neurocrine BioSciences, Inc.3$74
Janssen Pharmaceuticals, Inc3$64
Alkermes, Inc.3$56
Supernus Pharmaceuticals, Inc.3$54

Products named: VRAYLAR, TRINTELLIX, REXULTI, Xelstrym, Auvelity, CAPLYTA, INGREZZA, SPRAVATO.

Industry payments across IL — which companies pay providers there.